A lesion- and pathogen-targeted antibiotic-free phototheranostic platform based on Treponema pallidum-activated macrophage membranes for syphilis lesion treatment

Benzathine penicillin G (BPG) is the first-line therapy for syphilis; however, its widespread application is significantly hampered by allergic reactions and unpredictable supply chain disruptions. These limitations pose substantial clinical and public health challenges, particularly in resource-limited settings where syphilis remains endemic. To address these limitations, we developed a lesion- and pathogen-targeted phototheranostic platform (BDP@TM NPs) for the treatment of syphilis by integrating an aggregation-induced emission phototherapeutic agent borondipyrromethene (BDP) into T. pallidum -preactivated macrophage membranes. BDP@TM NPs retained adhesion molecules and a TLR2-enriched membrane phenotype derived from preactivated macrophages, which were associated with enhanced accumulation at syphilitic lesions and increased interaction with T. pallidum , thereby enhancing the combined photothermal and photodynamic antibacterial activity. This treatment exhibited therapeutic effects approaching that of BPG for local lesion regression in the rabbit primary-lesion model. More importantly, BDP@TM NPs can interact with activated vascular endothelial cells at the infected site, reducing T. pallidum adhesion and potentially limiting pathogen dissemination. This study pioneers the integration of membrane biomimetic strategies with photo-driven theranostics, offering an innovative antibiotic-free paradigm for primary syphilis lesion management and providing a basis for further preclinical development. BDP NPs are combined with membranes from Treponema pallidum-activated macrophages to form BDP@TM NPs. In a rabbit model of primary syphilis, the nanoparticles target lesions, bind to the bacteria, and enable imaging-guided killing under an 808 nm NIR laser through photothermal and photodynamic therapy

Authors

Institutions

Publication Details

Journal
Journal of Nanobiotechnology
Published
2026-11-16
DOI
https://doi.org/10.1186/s12951-026-05218-z
Primary Topic
Nanoplatforms for cancer theranostics
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

A lesion- and pathogen-targeted antibiotic-free phototheranostic platform based on Treponema pallidum-activated macrophage membranes for syphilis lesion treatment

Juewei Ning, Qin Zeng, Minying Li, Yuhui Liao et al.
3 links
Journal of Nanobiotechnology
Nanoplatforms for cancer theranostics
article

A lesion- and pathogen-targeted antibiotic-free phototheranostic platform based on Treponema pallidum-activated macrophage membranes for syphilis lesion treatment

Juewei Ning, Qin Zeng, Minying Li, Yuhui Liao, Xu Chen, Yunxia Wu, Qiulin Xie, Minghai Zhao, Jinxiong Lin, Zeyu Liu, Judun Zheng, Jialin Huang, Wei Wang, Xipeng Li
article en

Abstract

Benzathine penicillin G (BPG) is the first-line therapy for syphilis; however, its widespread application is significantly hampered by allergic reactions and unpredictable supply chain disruptions. These limitations pose substantial clinical and public health challenges, particularly in resource-limited settings where syphilis remains endemic. To address these limitations, we developed a lesion- and pathogen-targeted phototheranostic platform (BDP@TM NPs) for the treatment of syphilis by integrating an aggregation-induced emission phototherapeutic agent borondipyrromethene (BDP) into T. pallidum -preactivated macrophage membranes. BDP@TM NPs retained adhesion molecules and a TLR2-enriched membrane phenotype derived from preactivated macrophages, which were associated with enhanced accumulation at syphilitic lesions and increased interaction with T. pallidum , thereby enhancing the combined photothermal and photodynamic antibacterial activity. This treatment exhibited therapeutic effects approaching that of BPG for local lesion regression in the rabbit primary-lesion model. More importantly, BDP@TM NPs can interact with activated vascular endothelial cells at the infected site, reducing T. pallidum adhesion and potentially limiting pathogen dissemination. This study pioneers the integration of membrane biomimetic strategies with photo-driven theranostics, offering an innovative antibiotic-free paradigm for primary syphilis lesion management and providing a basis for further preclinical development. BDP NPs are combined with membranes from Treponema pallidum-activated macrophages to form BDP@TM NPs. In a rabbit model of primary syphilis, the nanoparticles target lesions, bind to the bacteria, and enable imaging-guided killing under an 808 nm NIR laser through photothermal and photodynamic therapy

Journal of Nanobiotechnology
Kunming Medical University (CN), Gannan Medical University (CN), Ningxia Medical University (CN), Southern Medical University (CN)
Good health and well-being
Nanoplatforms for cancer theranostics
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon